| STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma (NCT00006357) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-08-01 |
| Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma (NCT01560026) | Taipei Veterans General Hospital, Taiwan | 2000-08-01 |
| Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer (NCT00006027) | Radiation Therapy Oncology Group | 2000-08-01 |
| Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00006377) | Memorial Sloan Kettering Cancer Center | 2000-06-01 |
| Chemotherapy in Treating Patients With Sarcoma of the Uterus (NCT00005643) | Gynecologic Oncology Group | 2000-05-01 |
| Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer (NCT00005861) | Gynecologic Oncology Group | 2000-05-01 |
| Bone Mineral Density and Subsequent Cancer Risk (NCT00340262) | National Cancer Institute (NCI) | 2000-04-07 |
| Specimen and Data Study for Ovarian Cancer Early Detection and Prevention (NCT00005095) | Northwestern University | 2000-03-01 |
| Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer (NCT00004251) | NCIC Clinical Trials Group | 2000-01-19 |
| Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China (NCT01761409) | Third Affiliated Hospital, Sun Yat-Sen University | 2000-01-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer (NCT00005583) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2000-01-01 |
| Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT00071929) | Gynecologic Oncology Group | 1999-11-01 |
| Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer (NCT00003946) | Gynecologic Oncology Group | 1999-08-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors (NCT00004082) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Quality of Life in Survivors of Gynecologic Cancer (NCT00003795) | Gynecologic Oncology Group | 1999-04-01 |
| Extended Follow-up of Columbia, MO Serum Bank Participants (NCT00340210) | National Cancer Institute (NCI) | 1999-01-14 |
| Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00003691) | Gynecologic Oncology Group | 1998-12-01 |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer (NCT00003624) | Gynecologic Oncology Group | 1998-12-01 |
| Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer (NCT00003669) | Eli Lilly and Company | 1998-11-01 |
| Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer (NCT00003179) | Gynecologic Oncology Group | 1998-11-01 |
| Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT00004915) | Northwestern University | 1998-11-01 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003718) | Herbert Irving Comprehensive Cancer Center | 1998-09-01 |
| Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00003560) | Herbert Irving Comprehensive Cancer Center | 1998-05-01 |
| Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer (NCT00003749) | Medical Research Council | 1998-04-01 |
| Continuation of Follow-up of DES-Exposed Cohorts (NCT00340600) | National Cancer Institute (NCI) | 1998-03-18 |
| S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer (NCT00003127) | SWOG Cancer Research Network | 1998-02-01 |
| Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer (NCT00003267) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-02-01 |
| Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer (NCT00003821) | Genzyme, a Sanofi Company | 1998-01-01 |
| Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer (NCT00003135) | The University of Texas Health Science Center, Houston | 1997-11-01 |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors (NCT00019331) | National Cancer Institute (NCI) | 1997-10-01 |
| Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer (NCT00002976) | Gynecologic Oncology Group | 1997-06-01 |
| Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract (NCT00003334) | NYU Langone Health | 1997-03-01 |
| S9630, Medroxyprogesterone in Treating Women With Breast Cancer (NCT00002920) | SWOG Cancer Research Network | 1997-03-01 |
| Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery (NCT00002807) | NCIC Clinical Trials Group | 1996-07-04 |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis (NCT00002949) | University of Chicago | 1996-07-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma (NCT00002764) | European Organisation for Research and Treatment of Cancer - EORTC | 1996-04-01 |
| A Follow-up Study of Women Evaluated and Treated for Infertility (NCT00342446) | National Cancer Institute (NCI) | 1995-10-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma (NCT00002641) | European Organisation for Research and Treatment of Cancer - EORTC | 1995-02-01 |
| The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) (NCT01447199) | M.D. Anderson Cancer Center | 1994-09-01 |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer (NCT00002493) | Gynecologic Oncology Group | 1992-05-01 |
| The French E3N Prospective Cohort Study (NCT03285230) | Institut National de la Santé Et de la Recherche Médicale, France | 1990-06-15 |
| Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus (NCT00002459) | European Organisation for Research and Treatment of Cancer - EORTC | 1988-04-01 |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma (NCT00002465) | St. Vincent Medical Center - Los Angeles | 1987-12-01 |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248) | Leap Therapeutics, Inc. | |
| Karyopharm Expanded Access Program for Selinexor (NCT07215832) | Karyopharm Therapeutics Inc | |
| Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells (NCT01267461) | Meir Medical Center | |
| Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00003939) | European Organisation for Research and Treatment of Cancer - EORTC | |
| Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer (NCT00482300) | University of Roma La Sapienza | |